{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:40:35Z","timestamp":1783644035441,"version":"3.55.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00424-020-02486-y","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T07:14:16Z","timestamp":1605683656000},"page":"1151-1165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine"],"prefix":"10.1007","volume":"473","author":[{"given":"Ziwei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3735","authenticated-orcid":false,"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"2486_CR1","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","volume":"116","author":"H Abriel","year":"2015","unstructured":"Abriel H, Rougier JS, Jalife J (2015) Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death. Circ Res 116:1971\u20131988. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305017","journal-title":"Circ Res"},{"key":"2486_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biologicals.2015.07.007","volume":"43","author":"T Aoi","year":"2015","unstructured":"Aoi T, Stacey G (2015) Impact of national and international stem cell banking initiatives on progress in the field of cell therapy: IABS-JST joint workshop: summary for session 5. Biologicals 43:399\u2013401. https:\/\/doi.org\/10.1016\/j.biologicals.2015.07.007","journal-title":"Biologicals"},{"key":"2486_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/ncpcardio1182","volume":"5","author":"MM Awad","year":"2008","unstructured":"Awad MM, Calkins H, Judge DP (2008) Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Nat Clin Pract Cardiovasc Med 5:258\u2013267. https:\/\/doi.org\/10.1038\/ncpcardio1182","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2486_CR4","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/eurheartj\/ehz308","volume":"40","author":"N Belbachir","year":"2019","unstructured":"Belbachir N, Portero V, Al Sayed ZR, Gourraud JB, Dilasser F, Jesel L, Guo H, Wu H, Gaborit N, Guilluy C, Girardeau A, Bonnaud S, Simonet F, Karakachoff M, Pattier S, Scott C, Burel S, Marionneau C, Chariau C, Gaignerie A, David L, Genin E, Deleuze JF, Dina C, Sauzeau V, Loirand G, Bar\u00f3 I, Schott JJ, Probst V, Wu JC, Redon R, Charpentier F, Le Scouarnec S (2019) RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome. Eur Heart J 40:3081\u20133094. https:\/\/doi.org\/10.1093\/eurheartj\/ehz308","journal-title":"Eur Heart J"},{"key":"2486_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stemcr.2019.07.004","volume":"13","author":"MJ Birket","year":"2019","unstructured":"Birket MJ, Raibaud S, Lettieri M, Adamson AD, Letang V, Cervello P, Redon N, Ret G, Viale S, Wang B, Biton B, Guillemot JC, Mikol V, Leonard JP, Hanley NA, Orsini C, Itier JM (2019) A human stem cell model of Fabry disease implicates LIMP-2 accumulation in cardiomyocyte pathology. Stem Cell Reports 13:380\u2013393. https:\/\/doi.org\/10.1016\/j.stemcr.2019.07.004","journal-title":"Stem Cell Reports"},{"key":"2486_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrg3555","volume":"14","author":"KM Boycott","year":"2013","unstructured":"Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE (2013) Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 14:681\u2013691. https:\/\/doi.org\/10.1038\/nrg3555","journal-title":"Nat Rev Genet"},{"key":"2486_CR7","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/ijms20184381","volume":"20","author":"A Brodehl","year":"2019","unstructured":"Brodehl A, Ebbinghaus H, Deutsch MA, Gummert J, G\u00e4rtner A, Ratnavadivel S, Milting H (2019) Human induced pluripotent stem-cell-derived cardiomyocytes as models for genetic cardiomyopathies. Int J Mol Sci 20:4381. https:\/\/doi.org\/10.3390\/ijms20184381","journal-title":"Int J Mol Sci"},{"key":"2486_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-j","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391\u20131396. https:\/\/doi.org\/10.1016\/0735-1097(92)90253-j","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.stem.2011.12.013","volume":"10","author":"PW Burridge","year":"2012","unstructured":"Burridge PW, Keller G, Gold JD, Wu JC (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10:16\u201328. https:\/\/doi.org\/10.1016\/j.stem.2011.12.013","journal-title":"Cell Stem Cell"},{"key":"2486_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/CIRCGENETICS.113.000188","volume":"6","author":"O Caspi","year":"2013","unstructured":"Caspi O, Huber I, Gepstein A, Arbel G, Maizels L, Boulos M, Gepstein L (2013) Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ Cardiovasc Genet 6:557\u2013568. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000188","journal-title":"Circ Cardiovasc Genet"},{"key":"2486_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/circulationaha.113.003077","volume":"129","author":"M Cerrone","year":"2014","unstructured":"Cerrone M, Lin X, Zhang M, Agullo-Pascual E, Pfenniger A, Chkourko Gusky H, Novelli V, Kim C, Tirasawadichai T, Judge DP, Rothenberg E, Chen HS, Napolitano C, Priori SG, Delmar M (2014) Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation 129:1092\u20131103. https:\/\/doi.org\/10.1161\/circulationaha.113.003077","journal-title":"Circulation"},{"key":"2486_CR12","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/ijms19051480","volume":"19","author":"Y Chien","year":"2018","unstructured":"Chien Y, Chou SJ, Chang YL, Leu HB, Yang YP, Tsai PH, Lai YH, Chen KH, Chang WC, Sung SH, Yu WC (2018) Inhibition of arachidonate 12\/15-lipoxygenase improves \u03b1-galactosidase efficacy in iPSC-derived cardiomyocytes from Fabry patients. Int J Mol Sci 19:1480. https:\/\/doi.org\/10.3390\/ijms19051480","journal-title":"Int J Mol Sci"},{"key":"2486_CR13","unstructured":"Chinese Organization for Rare Disease (2019) Chinese rare disease drug accessibility report. Chinese Organization for Rare Disease"},{"key":"2486_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0008-6363(00)00293-5","volume":"50","author":"CE Clancy","year":"2001","unstructured":"Clancy CE, Rudy Y (2001) Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death. Cardiovasc Res 50:301\u2013313. https:\/\/doi.org\/10.1016\/s0008-6363(00)00293-5","journal-title":"Cardiovasc Res"},{"key":"2486_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793\u2013795. https:\/\/doi.org\/10.1056\/NEJMp1500523","journal-title":"N Engl J Med"},{"key":"2486_CR16","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/s41598-017-08713-4","volume":"7","author":"C Correia","year":"2017","unstructured":"Correia C, Koshkin A, Duarte P, Hu D, Teixeira A, Domian I, Serra M, Alves PM (2017) Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci Rep 7:8590\u20138590. https:\/\/doi.org\/10.1038\/s41598-017-08713-4","journal-title":"Sci Rep"},{"key":"2486_CR17","unstructured":"Council of the European Union & European Parliament (1999) Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products"},{"key":"2486_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jacbts.2018.01.003","volume":"3","author":"AM Dainis","year":"2018","unstructured":"Dainis AM, Ashley EA (2018) Cardiovascular precision medicine in the genomics era. JACC Basic Transl Sci 3:313\u2013326. https:\/\/doi.org\/10.1016\/j.jacbts.2018.01.003","journal-title":"JACC Basic Transl Sci"},{"key":"2486_CR19","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.111.066092","volume":"125","author":"RP Davis","year":"2012","unstructured":"Davis RP, Casini S, van den Berg CW, Hoekstra M, Remme CA, Dambrot C, Salvatori D, Oostwaard DW, Wilde AA, Bezzina CR, Verkerk AO, Freund C, Mummery CL (2012) Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125:3079\u20133091. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.066092","journal-title":"Circulation"},{"key":"2486_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1134\/S0006297919030118","volume":"84","author":"EV Dementyeva","year":"2019","unstructured":"Dementyeva EV, Medvedev SP, Kovalenko VR, Vyatkin YV, Kretov EI, Slotvitsky MM, Shtokalo DN, Pokushalov EA, Zakian SM (2019) Applying patient-specific induced pluripotent stem cells to create a model of hypertrophic cardiomyopathy. Biochemistry (Mosc) 84:291\u2013298. https:\/\/doi.org\/10.1134\/S0006297919030118","journal-title":"Biochemistry (Mosc)"},{"key":"2486_CR21","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.1038\/cddis.2013.369","volume":"4","author":"E Di Pasquale","year":"2013","unstructured":"Di Pasquale E, Lodola F, Miragoli M, Denegri M, Avelino-Cruz JE, Buonocore M, Nakahama H, Portararo P, Bloise R, Napolitano C, Condorelli G, Priori SG (2013) CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis 4:e843. https:\/\/doi.org\/10.1038\/cddis.2013.369","journal-title":"Cell Death Dis"},{"key":"2486_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/circresaha.118.313973","volume":"125","author":"A Ebert","year":"2019","unstructured":"Ebert A, Joshi AU, Andorf S, Dai Y, Sampathkumar S, Chen H, Li Y, Garg P, Toischer K, Hasenfuss G, Mochly-Rosen D, Wu JC (2019) Proteasome-dependent regulation of distinct metabolic states during long-term culture of human iPSC-derived cardiomyocytes. Circ Res 125:90\u2013103. https:\/\/doi.org\/10.1161\/circresaha.118.313973","journal-title":"Circ Res"},{"key":"2486_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/cvr\/cvs206","volume":"95","author":"T Egashira","year":"2012","unstructured":"Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, Tohyama S, Okata S, Seki T, Kuroda Y, Yae K, Hashimoto H, Tanaka T, Hattori F, Sato T, Miyoshi S, Takatsuki S, Murata M, Kurokawa J, Furukawa T, Makita N, Aiba T, Shimizu W, Horie M, Kamiya K, Kodama I, Ogawa S, Fukuda K (2012) Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res 95:419\u2013429. https:\/\/doi.org\/10.1093\/cvr\/cvs206","journal-title":"Cardiovasc Res"},{"key":"2486_CR24","doi-asserted-by":"publisher","first-page":"e007394","DOI":"10.1161\/JAHA.117.007394","volume":"7","author":"I El-Battrawy","year":"2018","unstructured":"El-Battrawy I, Lan H, Cyganek L, Zhao Z, Li X, Buljubasic F, Lang S, Y\u00fccel G, Sattler K, Zimmermann WH, Utikal J, Wieland T, Ravens U, Borggrefe M, Zhou XB, Akin I (2018) Modeling short QT syndrome using human-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc 7:e007394. https:\/\/doi.org\/10.1161\/JAHA.117.007394","journal-title":"J Am Heart Assoc"},{"key":"2486_CR25","doi-asserted-by":"publisher","first-page":"f46","DOI":"10.1093\/europace\/euy042","volume":"20","author":"I El-Battrawy","year":"2018","unstructured":"El-Battrawy I, Zhao Z, Lan H, Cyganek L, Tombers C, Li X, Buljubasic F, Lang S, Tiburcy M, Zimmermann WH, Utikal J, Wieland T, Borggrefe M, Zhou XB, Akin I (2018) Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. Europace 20:f46\u2013f56. https:\/\/doi.org\/10.1093\/europace\/euy042","journal-title":"Europace"},{"key":"2486_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1096\/fasebj.11.8.9240969","volume":"11","author":"T Eschenhagen","year":"1997","unstructured":"Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Sch\u00e4fer H, Bishopric N, Wakatsuki T, Elson EL (1997) Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11:683\u2013694. https:\/\/doi.org\/10.1096\/fasebj.11.8.9240969","journal-title":"FASEB J"},{"key":"2486_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/292154a0","volume":"292","author":"MJ Evans","year":"1981","unstructured":"Evans MJ (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154\u2013156","journal-title":"Nature"},{"key":"2486_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000335753","volume":"28","author":"A Fatima","year":"2011","unstructured":"Fatima A, Xu G, Shao K, Papadopoulos S, Lehmann M, Arn\u00e1iz-Cot JJ, Rosa AO, Nguemo F, Matzkies M, Dittmann S, Stone SL, Linke M, Zechner U, Beyer V, Hennies HC, Rosenkranz S, Klauke B, Parwani AS, Haverkamp W, Pfitzer G, Farr M, Cleemann L, Morad M, Milting H, Hescheler J, Saric T (2011) In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell Physiol Biochem 28:579\u2013592. https:\/\/doi.org\/10.1159\/000335753","journal-title":"Cell Physiol Biochem"},{"key":"2486_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biology6010007","volume":"6","author":"A Fern\u00e1ndez-Falgueras","year":"2017","unstructured":"Fern\u00e1ndez-Falgueras A, Sarquella-Brugada G, Brugada J, Brugada R, Campuzano O (2017) Cardiac channelopathies and sudden death: recent clinical and genetic advances. Biology 6:7. https:\/\/doi.org\/10.3390\/biology6010007","journal-title":"Biology"},{"key":"2486_CR30","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","volume":"43","author":"F Gaita","year":"2004","unstructured":"Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Cal\u00f2 L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494\u20131499. https:\/\/doi.org\/10.1016\/j.jacc.2004.02.034","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30\u201330. https:\/\/doi.org\/10.1186\/1750-1172-5-30","journal-title":"Orphanet J Rare Dis"},{"key":"2486_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.15252\/emmm.201505047","volume":"7","author":"M Gramlich","year":"2015","unstructured":"Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Sch\u00f6tterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz KL, Gawaz MP, Moretti A (2015) Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Molecular Medicine 7:562\u2013576. https:\/\/doi.org\/10.15252\/emmm.201505047","journal-title":"EMBO Molecular Medicine"},{"key":"2486_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCRESAHA.118.313518","volume":"124","author":"F Guo","year":"2019","unstructured":"Guo F, Sun Y, Wang X, Wang H, Wang J, Gong T, Chen X, Zhang P, Su L, Fu G, Su J, Yang S, Lai R, Jiang C, Liang P (2019) Patient-specific and gene-corrected induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of short QT syndrome. Circ Res 124:66\u201378. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313518","journal-title":"Circ Res"},{"key":"2486_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000047299","volume":"94","author":"I Gussak","year":"2000","unstructured":"Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99\u2013102. https:\/\/doi.org\/10.1159\/000047299","journal-title":"Cardiology"},{"key":"2486_CR35","unstructured":"H. R (2002) One Hundred Seventh Congress of the United States of America"},{"key":"2486_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1172\/JCI17892","volume":"111","author":"K Haghighi","year":"2003","unstructured":"Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW 2nd, MacLennan DH, Kremastinos DT, Kranias EG (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111:869\u2013876. https:\/\/doi.org\/10.1172\/JCI17892","journal-title":"J Clin Invest"},{"key":"2486_CR37","doi-asserted-by":"publisher","first-page":"e003638","DOI":"10.1161\/CIRCEP.113.003638","volume":"9","author":"TJ Herron","year":"2016","unstructured":"Herron TJ, Rocha AMD, Campbell KF, Ponce-Balbuena D, Willis BC, Guerrero-Serna G, Liu Q, Klos M, Musa H, Zarzoso M, Bizy A, Furness J, Anumonwo J, Mironov S, Jalife J (2016) Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circ Arrhythm Electrophysiol 9:e003638. https:\/\/doi.org\/10.1161\/CIRCEP.113.003638","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2486_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fphys.2012.00346","volume":"3","author":"M Hoekstra","year":"2012","unstructured":"Hoekstra M, Mummery CL, Wilde AAM, Bezzina CR, Verkerk AO (2012) Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 3:346\u2013346. https:\/\/doi.org\/10.3389\/fphys.2012.00346","journal-title":"Front Physiol"},{"key":"2486_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCGENETICS.108.829192","volume":"2","author":"D Hu","year":"2009","unstructured":"Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick GD, Antzelevitch C (2009) A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2:270\u2013278. https:\/\/doi.org\/10.1161\/CIRCGENETICS.108.829192","journal-title":"Circ Cardiovasc Genet"},{"key":"2486_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10545-014-9724-5","volume":"37","author":"JM Itier","year":"2014","unstructured":"Itier JM, Ret G, Viale S, Sweet L, Bangari D, Caron A, Le-Gall F, B\u00e9nichou B, Leonard J, Deleuze JF, Orsini C (2014) Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease. J Inherit Metab Dis 37:1013\u20131022. https:\/\/doi.org\/10.1007\/s10545-014-9724-5","journal-title":"J Inherit Metab Dis"},{"key":"2486_CR41","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jacc.2012.02.066","volume":"60","author":"I Itzhaki","year":"2012","unstructured":"Itzhaki I, Maizels L, Huber I, Gepstein A, Arbel G, Caspi O, Miller L, Belhassen B, Nof E, Glikson M, Gepstein L (2012) Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol 60:990\u20131000. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.066","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","volume":"471","author":"I Itzhaki","year":"2011","unstructured":"Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471:225\u2013229. https:\/\/doi.org\/10.1038\/nature09747","journal-title":"Nature"},{"key":"2486_CR43","doi-asserted-by":"publisher","first-page":"H913","DOI":"10.1152\/ajpheart.00819.2012","volume":"305","author":"CY Ivashchenko","year":"2013","unstructured":"Ivashchenko CY, Pipes GC, Lozinskaya IM, Lin Z, Xiaoping X, Needle S, Grygielko ET, Hu E, Toomey JR, Lepore JJ, Willette RN (2013) Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am J Phys Heart Circ Phys 305:H913\u2013H922. https:\/\/doi.org\/10.1152\/ajpheart.00819.2012","journal-title":"Am J Phys Heart Circ Phys"},{"key":"2486_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","volume":"33","author":"D Jacoby","year":"2012","unstructured":"Jacoby D, McKenna WJ (2012) Genetics of inherited cardiomyopathy. Eur Heart J 33:296\u2013304. https:\/\/doi.org\/10.1093\/eurheartj\/ehr260","journal-title":"Eur Heart J"},{"key":"2486_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0002-8703(57)90079-0","volume":"54","author":"A Jervell","year":"1957","unstructured":"Jervell A, Lange-Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 54:59\u201368. https:\/\/doi.org\/10.1016\/0002-8703(57)90079-0","journal-title":"Am Heart J"},{"key":"2486_CR46","doi-asserted-by":"publisher","first-page":"D937","DOI":"10.1093\/nar\/gkx1062","volume":"46","author":"J Jia","year":"2018","unstructured":"Jia J, An Z, Ming Y, Guo Y, Li W, Liang Y, Guo D, Li X, Tai J, Chen G, Jin Y, Liu Z, Ni X, Shi T (2018) eRAM: encyclopedia of rare disease annotations for precision medicine. Nucleic Acids Res 46:D937\u2013D943. https:\/\/doi.org\/10.1093\/nar\/gkx1062","journal-title":"Nucleic Acids Res"},{"key":"2486_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/emmm.201100194","volume":"4","author":"CB Jung","year":"2012","unstructured":"Jung CB, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, Dorn T, Ruppenthal S, Pfeiffer S, Goedel A, Dirschinger RJ, Seyfarth M, Lam JT, Sinnecker D, Gudermann T, Lipp P, Laugwitz KL (2012) Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 4:180\u2013191. https:\/\/doi.org\/10.1002\/emmm.201100194","journal-title":"EMBO Mol Med"},{"key":"2486_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ymgme.2013.06.003","volume":"109","author":"S Kawagoe","year":"2013","unstructured":"Kawagoe S, Higuchi T, Otaka M, Shimada Y, Kobayashi H, Ida H, Ohashi T, Okano HJ, Nakanishi M, Eto Y (2013) Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp). Mol Genet Metab 109:386\u2013389. https:\/\/doi.org\/10.1016\/j.ymgme.2013.06.003","journal-title":"Mol Genet Metab"},{"key":"2486_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI12131","volume":"108","author":"I Kehat","year":"2001","unstructured":"Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407\u2013414. https:\/\/doi.org\/10.1172\/JCI12131","journal-title":"J Clin Invest"},{"key":"2486_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature11799","volume":"494","author":"C Kim","year":"2013","unstructured":"Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494:105\u2013110. https:\/\/doi.org\/10.1038\/nature11799","journal-title":"Nature"},{"key":"2486_CR51","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1089\/scd.2014.0167","volume":"23","author":"HS Kim","year":"2014","unstructured":"Kim HS, Bernitz JM, Lee DF, Lemischka IR (2014) Genomic editing tools to model human diseases with isogenic pluripotent stem cells. Stem Cells Dev 23:2673\u20132686. https:\/\/doi.org\/10.1089\/scd.2014.0167","journal-title":"Stem Cells Dev"},{"key":"2486_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1242\/dmm.008409","volume":"5","author":"AL Lahti","year":"2012","unstructured":"Lahti AL, Kujala VJ, Chapman H, Koivisto AP, Pekkanen-Mattila M, Kerkel\u00e4 E, Hyttinen J, Kontula K, Swan H, Conklin BR, Yamanaka S, Silvennoinen O, Aalto-Set\u00e4l\u00e4 K (2012) Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech 5:220\u2013230. https:\/\/doi.org\/10.1242\/dmm.008409","journal-title":"Dis Model Mech"},{"key":"2486_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","volume":"12","author":"F Lan","year":"2013","unstructured":"Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, Abilez OJ, Hu S, Ebert AD, Navarrete EG, Simmons CS, Wheeler M, Pruitt B, Lewis R, Yamaguchi Y, Ashley EA, Bers DM, Robbins RC, Longaker MT, Wu JC (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12:101\u2013113. https:\/\/doi.org\/10.1016\/j.stem.2012.10.010","journal-title":"Cell Stem Cell"},{"key":"2486_CR54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","volume":"60","author":"LJ Laslett","year":"2012","unstructured":"Laslett LJ, Alagona P Jr, Clark BA 3rd, Drozda JP Jr, Saldivar F, Wilson SR, Poe C, Hart M (2012) The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 60:S1\u2013S49. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.002","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.stem.2017.07.003","volume":"21","author":"JH Lee","year":"2017","unstructured":"Lee JH, Protze SI, Laksman Z, Backx PH, Keller GM (2017) Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations. Cell Stem Cell 21:179\u2013194.e174. https:\/\/doi.org\/10.1016\/j.stem.2017.07.003","journal-title":"Cell Stem Cell"},{"key":"2486_CR56","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00424-013-1414-x","volume":"466","author":"YK Lee","year":"2014","unstructured":"Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, Li Y, Ng KM, Ho SL, Esteban MA, Binah O, Tse HF, Siu CW (2014) Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Arch Eur J Physiol 466:1831\u20131844. https:\/\/doi.org\/10.1007\/s00424-013-1414-x","journal-title":"Arch Eur J Physiol"},{"key":"2486_CR57","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.jacc.2016.07.779","volume":"68","author":"P Liang","year":"2016","unstructured":"Liang P, Sallam K, Wu H, Li Y, Itzhaki I, Garg P, Zhang Y, Vermglinchan V, Lan F, Gu M, Gong T, Zhuge Y, He C, Ebert AD, Sanchez-Freire V, Churko J, Hu S, Sharma A, Lam CK, Scheinman MM, Bers DM, Wu JC (2016) Patient-specific and genome-edited induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome. J Am Coll Cardiol 68:2086\u20132096. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.779","journal-title":"J Am Coll Cardiol"},{"key":"2486_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pcad.2007.10.005","volume":"51","author":"N Liu","year":"2008","unstructured":"Liu N, Ruan Y, Priori SG (2008) Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 51:23\u201330. https:\/\/doi.org\/10.1016\/j.pcad.2007.10.005","journal-title":"Prog Cardiovasc Dis"},{"key":"2486_CR59","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/eurheartj\/ehs226","volume":"34","author":"D Ma","year":"2013","unstructured":"Ma D, Wei H, Lu J, Ho S, Zhang G, Sun X, Oh Y, Tan SH, Ng ML, Shim W, Wong P, Liew R (2013) Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 34:1122\u20131133. https:\/\/doi.org\/10.1093\/eurheartj\/ehs226","journal-title":"Eur Heart J"},{"key":"2486_CR60","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1016\/j.ijcard.2013.08.015","volume":"168","author":"D Ma","year":"2013","unstructured":"Ma D, Wei H, Zhao Y, Lu J, Li G, Sahib NBE, Tan TH, Wong KY, Shim W, Wong P, Cook SA, Liew R (2013) Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int J Cardiol 168:5277\u20135286. https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.015","journal-title":"Int J Cardiol"},{"issue":"Suppl 1","key":"2486_CR61","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1186\/scrt375","volume":"4","author":"A Mathur","year":"2013","unstructured":"Mathur A, Loskill P, Hong S, Lee J, Marcus SG, Dumont L, Conklin BR, Willenbring H, Lee LP, Healy KE (2013) Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem Cell Res Ther 4(Suppl 1):S14\u2013S14. https:\/\/doi.org\/10.1186\/scrt375","journal-title":"Stem Cell Res Ther"},{"key":"2486_CR62","unstructured":"Ministry of Health Labour and Welfare of Japan (2009) Overview of orphan drug\/medical device designation system"},{"key":"2486_CR63","first-page":"1149","volume":"63","author":"H Mitani","year":"2005","unstructured":"Mitani H, Momomura S (2005) Idiopathic cardiomyopathy. Nihon Rinsho 63:1149\u20131154","journal-title":"Nihon Rinsho"},{"key":"2486_CR64","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","volume":"363","author":"A Moretti","year":"2010","unstructured":"Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Fl\u00fcgel L, Dorn T, Goedel A, H\u00f6hnke C, Hofmann F, Seyfarth M, Sinnecker D, Sch\u00f6mig A, Laugwitz KL (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363:1397\u20131409. https:\/\/doi.org\/10.1056\/NEJMoa0908679","journal-title":"N Engl J Med"},{"key":"2486_CR65","unstructured":"National Health Commission of the People's Republic of China (2018) Notification of the Publication of the First Catalogue of Rare Diseases"},{"key":"2486_CR66","unstructured":"National Institutes of Health Rare Diseases Clinical Research Network Fact Sheet. National Institutes of Health. http:\/\/report.nih.gov\/nihfactsheets\/Pdfs\/"},{"key":"2486_CR67","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1582-4934.2011.01476.x","volume":"16","author":"A Novak","year":"2012","unstructured":"Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, Lorber A, Itskovitz-Eldor J, Binah O (2012) Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to \u03b2-adrenergic stimulation. J Cell Mol Med 16:468\u2013482. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01476.x","journal-title":"J Cell Mol Med"},{"key":"2486_CR68","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nmeth.2524","volume":"10","author":"SS Nunes","year":"2013","unstructured":"Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Mass\u00e9 S, Gagliardi M, Hsieh A, Thavandiran N, Laflamme MA, Nanthakumar K, Gross GJ, Backx PH, Keller G, Radisic M (2013) Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10:781\u2013787. https:\/\/doi.org\/10.1038\/nmeth.2524","journal-title":"Nat Methods"},{"key":"2486_CR69","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/circulationaha.119.039711","volume":"140","author":"SJ Park","year":"2019","unstructured":"Park SJ, Zhang D, Qi Y, Li Y, Lee KY, Bezzerides VJ, Yang P, Xia S, Kim SL, Liu X, Lu F, Pasqualini FS, Campbell PH, Geva J, Roberts AE, Kleber AG, Abrams DJ, Pu WT, Parker KK (2019) Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue. Circulation 140:390\u2013404. https:\/\/doi.org\/10.1161\/circulationaha.119.039711","journal-title":"Circulation"},{"key":"2486_CR70","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/eurheartj\/ehw160","volume":"37","author":"DG Phelan","year":"2016","unstructured":"Phelan DG, Anderson DJ, Howden SE, Wong RC, Hickey PF, Pope K, Wilson GR, P\u00e9bay A, Davis AM, Petrou S, Elefanty AG, Stanley EG, James PA, Macciocca I, Bahlo M, Cheung MM, Amor DJ, Elliott DA, Lockhart PJ (2016) ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. Eur Heart J 37:2586\u20132590. https:\/\/doi.org\/10.1093\/eurheartj\/ehw160","journal-title":"Eur Heart J"},{"key":"2486_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D'Antoni ML, Debuque R, Chandran A, Wang L, Arora K, Rosenthal NA, Tallquist MD (2016) Revisiting cardiac cellular composition. Circ Res 118:400\u2013409. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307778","journal-title":"Circ Res"},{"key":"2486_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/9783527621460.ch3","volume-title":"Pharmacological and regulatory aspects of QT prolongation","author":"FD Ponti","year":"2008","unstructured":"Ponti FD (2008) Pharmacological and regulatory aspects of QT prolongation. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim"},{"issue":"1","key":"2486_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nbt.3745","volume":"35","author":"SI Protze","year":"2017","unstructured":"Protze SI, Liu J, Nussinovitch U, Ohana L, Backx PH, Gepstein L, Keller GM (2017) Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker. Nat Biotechnol 35(1):56\u201368. https:\/\/doi.org\/10.1038\/nbt.3745","journal-title":"Nat Biotechnol"},{"key":"2486_CR74","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/bies.201200053","volume":"35","author":"D Rajamohan","year":"2013","unstructured":"Rajamohan D, Matsa E, Kalra S, Crutchley J, Patel A, George V, Denning C (2013) Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays 35:281\u2013298. https:\/\/doi.org\/10.1002\/bies.201200053","journal-title":"Bioessays"},{"key":"2486_CR75","doi-asserted-by":"publisher","unstructured":"Rare Diseases and Orphan Drugs. In: Pediatric Drug Development, 2nd Edition. pp 130\u2013148. doi:https:\/\/doi.org\/10.1002\/9781118312087.ch13","DOI":"10.1002\/9781118312087.ch13"},{"key":"2486_CR76","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cge.12126","volume":"84","author":"B Risgaard","year":"2013","unstructured":"Risgaard B, Jabbari R, Refsgaard L, Holst AG, Hauns\u00f8 S, Sadjadieh A, Winkel BG, Olesen MS, Tfelt-Hansen J (2013) High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin Genet 84:489\u2013495. https:\/\/doi.org\/10.1111\/cge.12126","journal-title":"Clin Genet"},{"key":"2486_CR77","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","volume":"134","author":"J-L Ruan","year":"2016","unstructured":"Ruan J-L, Tulloch NL, Razumova MV, Saiget M, Muskheli V, Pabon L, Reinecke H, Regnier M, Murry CE (2016) Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134:1557\u20131567. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014998","journal-title":"Circulation"},{"key":"2486_CR78","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","volume":"167","author":"PT Sager","year":"2014","unstructured":"Sager PT, Gintant G, Turner JR, Pettit S, Stockbridge N (2014) Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium. Am Heart J 167:292\u2013300. https:\/\/doi.org\/10.1016\/j.ahj.2013.11.004","journal-title":"Am Heart J"},{"key":"2486_CR79","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/circresaha.116.304494","volume":"116","author":"K Sallam","year":"2015","unstructured":"Sallam K, Li Y, Sager PT, Houser SR, Wu JC (2015) Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes. Circ Res 116:1989\u20132004. https:\/\/doi.org\/10.1161\/circresaha.116.304494","journal-title":"Circ Res"},{"key":"2486_CR80","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","volume":"125","author":"AJ Sauer","year":"2012","unstructured":"Sauer AJ, Newton-Cheh C (2012) Clinical and genetic determinants of torsade de pointes risk. Circulation 125:1684\u20131694. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.080887","journal-title":"Circulation"},{"key":"2486_CR81","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","volume":"120","author":"PJ Schwartz","year":"2009","unstructured":"Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, Gabbarini F, Goulene K, Insolia R, Mannarino S, Mosca F, Nespoli L, Rimini A, Rosati E, Salice P, Spazzolini C (2009) Prevalence of the congenital long-QT syndrome. Circulation 120:1761\u20131767. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.863209","journal-title":"Circulation"},{"key":"2486_CR82","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","volume":"139","author":"T Seeger","year":"2019","unstructured":"Seeger T, Shrestha R, Lam CK, Chen C, McKeithan WL, Lau E, Wnorowski A, McMullen G, Greenhaw M, Lee J, Oikonomopoulos A, Lee S, Yang H, Mercola M, Wheeler M, Ashley EA, Yang F, Karakikes I, Wu JC (2019) A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay. Circulation 139:799\u2013811. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034624","journal-title":"Circulation"},{"key":"2486_CR83","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","volume":"108","author":"CE Seidman","year":"2011","unstructured":"Seidman CE, Seidman JG (2011) Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 108:743\u2013750. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223834","journal-title":"Circ Res"},{"key":"2486_CR84","doi-asserted-by":"publisher","first-page":"803","DOI":"10.18632\/aging.100503","volume":"4","author":"CW Siu","year":"2012","unstructured":"Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, Lay KW, Colman A, Tse HF (2012) Modeling of lamin A\/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells. Aging 4:803\u2013822. https:\/\/doi.org\/10.18632\/aging.100503","journal-title":"Aging"},{"key":"2486_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.biotechadv.2016.12.002","volume":"35","author":"AST Smith","year":"2017","unstructured":"Smith AST, Macadangdang J, Leung W, Laflamme MA, Kim DH (2017) Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. Biotechnol Adv 35:77\u201394. https:\/\/doi.org\/10.1016\/j.biotechadv.2016.12.002","journal-title":"Biotechnol Adv"},{"key":"2486_CR86","doi-asserted-by":"publisher","first-page":"130ra147","DOI":"10.1126\/scitranslmed.3003552","volume":"4","author":"N Sun","year":"2012","unstructured":"Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ, Navarrete EG, Hu S, Wang L, Lee A, Pavlovic A, Lin S, Chen R, Hajjar RJ, Snyder MP, Dolmetsch RE, Butte MJ, Ashley EA, Longaker MT, Robbins RC, Wu JC (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4:130ra147. https:\/\/doi.org\/10.1126\/scitranslmed.3003552","journal-title":"Sci Transl Med"},{"key":"2486_CR87","doi-asserted-by":"publisher","unstructured":"Sun X, Nunes SS (2017) Maturation of human stem cell-derived cardiomyocytes in biowires using electrical stimulation. J Vis Exp :55373. doi:https:\/\/doi.org\/10.3791\/55373","DOI":"10.3791\/55373"},{"key":"2486_CR88","doi-asserted-by":"publisher","unstructured":"Takahashi K (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 25, 126:\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","DOI":"10.1016\/j.cell.2006.07.024"},{"key":"2486_CR89","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"2486_CR90","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1085\/jgp.201210899","volume":"141","author":"C Terrenoire","year":"2013","unstructured":"Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G, Kass RS (2013) Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 141:61\u201372. https:\/\/doi.org\/10.1085\/jgp.201210899","journal-title":"J Gen Physiol"},{"key":"2486_CR91","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.hrthm.2005.01.020","volume":"2","author":"DJ Tester","year":"2005","unstructured":"Tester DJ, Will ML, Haglund CM, Ackerman MJ (2005) Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2:507\u2013517. https:\/\/doi.org\/10.1016\/j.hrthm.2005.01.020","journal-title":"Heart Rhythm"},{"key":"2486_CR92","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2174\/138161206777585102","volume":"12","author":"D Thomas","year":"2006","unstructured":"Thomas D, Karle CA, Kiehn J (2006) The cardiac hERG\/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Curr Pharm Des 12:2271\u20132283. https:\/\/doi.org\/10.2174\/138161206777585102","journal-title":"Curr Pharm Des"},{"key":"2486_CR93","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 282:1145\u20131147. https:\/\/doi.org\/10.1126\/science.282.5391.1145","journal-title":"Science (New York, NY)"},{"key":"2486_CR94","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/hmg\/dds556","volume":"22","author":"HF Tse","year":"2013","unstructured":"Tse HF, Ho JC, Choi SW, Lee YK, Butler AW, Ng KM, Siu CW, Simpson MA, Lai WH, Chan YC, Au KW, Zhang J, Lay KW, Esteban MA, Nicholls JM, Colman A, Sham PC (2013) Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet 22:1395\u20131403. https:\/\/doi.org\/10.1093\/hmg\/dds556","journal-title":"Hum Mol Genet"},{"key":"2486_CR95","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.addr.2015.09.010","volume":"96","author":"E Tzatzalos","year":"2016","unstructured":"Tzatzalos E, Abilez OJ, Shukla P, Wu JC (2016) Engineered heart tissues and induced pluripotent stem cells: macro- and microstructures for disease modeling, drug screening, and translational studies. Adv Drug Deliv Rev 96:234\u2013244. https:\/\/doi.org\/10.1016\/j.addr.2015.09.010","journal-title":"Adv Drug Deliv Rev"},{"key":"2486_CR96","unstructured":"What is precision medicine? (2019). https:\/\/ghr.nlm.nih.gov\/primer\/precisionmedicine\/definition"},{"key":"2486_CR97","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","volume":"114","author":"X Yang","year":"2014","unstructured":"Yang X, Pabon L, Murry CE (2014) Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114:511\u2013523. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.300558","journal-title":"Circ Res"},{"key":"2486_CR98","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/circresaha.117.311080","volume":"120","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Yamanaka S (2017) Induced pluripotent stem cells 10 years later: for cardiac applications. Circ Res 120:1958\u20131968. https:\/\/doi.org\/10.1161\/circresaha.117.311080","journal-title":"Circ Res"},{"key":"2486_CR99","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12265-019-09873-6","volume":"12","author":"W Zhou","year":"2019","unstructured":"Zhou W, Bos JM, Ye D, Tester DJ, Hrstka S, Maleszewski JJ, Ommen SR, Nishimura RA, Schaff HV, Kim CS, Ackerman MJ (2019) Induced pluripotent stem cell-derived cardiomyocytes from a patient with MYL2-R58Q-mediated apical hypertrophic cardiomyopathy show hypertrophy, myofibrillar disarray, and calcium perturbations. J Cardiovasc Transl Res 12:394\u2013403. https:\/\/doi.org\/10.1007\/s12265-019-09873-6","journal-title":"J Cardiovasc Transl Res"},{"key":"2486_CR100","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(SICI)1097-0290(20000405)68:1<106::AID-BIT13>3.0.CO;2-3","volume":"68","author":"WH Zimmermann","year":"2000","unstructured":"Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106\u2013114","journal-title":"Biotechnol Bioeng"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-020-02486-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-020-02486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T12:04:17Z","timestamp":1625054657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-020-02486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1007\/s00424-020-02486-y","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}